Aptamer Selection Center
This center is at the forefront of developing high-throughput and cost-effective screening technologies for the rapid generation of aptamers – single-stranded DNA or RNA molecules that can bind with high affinity and specificity to such targets as proteins, small molecules, or even cells. This center aims to overcome technical challenges and provide novel research tools and platforms specific to oncology and basic medical research.
Nucleic Acid Molecular Medicine Research Center
Center of Nucleic Acid Molecular Medicine is committed to the Healthy China strategy aimed at enhancing the prevention and treatment capabilities of major diseases. Through conducting basic research-driven nucleic acid molecular medicine studies, we aim to develop new technologies for efficient disease identification and precise intervention. Our focus includes advancing tumor diagnosis, treatment, and prevention methods at the molecular level, addressing fundamental scientific questions in the field of nucleic acid research, and overcoming technical bottlenecks.
Center for Intelligent Molecular Diagnostics
This center aims to develop precision detection technology by focusing on molecular diagnosis and automated detection of major diseases, including malignant tumors and infectious diseases. It is also working on instant intelligent detection equipment, home-based diagnostic solutions, and an AI and blockchain-assisted platform for medical big data analysis.
Center for Innovative Drugs and Precision Theranostics
The development of innovative drugs is a cornerstone of HIMCAS’s mission. This center tackles the technical barriers of cell therapy and is actively engaged in the development of small-molecule drug candidates. It also houses laboratories for gastric cancer intelligent surgery and proteomics research.
Medical Synthetic Biology Research Center
The research focus of this center’s teams encompasses various levels of artificial biological systems, such as non-natural nucleic acid and modified nucleic acid synthesis and optimization, functional nucleic acid drugs, mRNA drugs and vaccines, AI-driven protein design, artificial cells, and biopharmaceuticals. The center aims to foster innovation in basic research and develop clinical translational applications by manipulating artificially designed molecules, genes, cells, and devices.
Biomaterials & Medical Devices Research Center
The center’s research focuses on exploring the synthesis, properties, and potential applications of novel biomaterials and developing medical devices in areas such as medical imaging, in vitro diagnostics, vital signs monitoring, advanced therapies, and implantable/interventional devices. The center strives to foster technological advancements and innovations in biomaterials and medical devices, meet clinical requirements, and enhance therapeutic outcomes.
Omics & AI for Medicine Research Center
Omics & AI for Medicine Research Center is creating Intelligence towards GenAI and AGI, empowering drug discovery, multiomics, multimodal intelligent diagnosis, prognostics, and therapeutics. The Center upholds the holistic guiding principle of "big platform, big team, big project, and big achievement," strategically positioning three pivotal platforms: genomics, proteomics, and bioinformatics, all with a forward-thinking approach. It aims to develop capabilities in diverse fields, spanning from single-cell and STO to single-cell and spatial proteomics, big-data bioinformatics, regenerative medicine, and synthetic biology. By gathering innovative talents globally, the Center aspires to develop major scientific and technological engineering initiatives and projects, contributing to leading and defining achievements.
Clinical & Translational Research Center
The Clinical & Translation Research Center, in response to the “Healthy China” strategy and the unmet medical needs of malignant tumor prevention, control, and treatment, focuses on basic and clinical translational research of malignant tumors. The goal is to explore the mechanisms of tumor occurrence and progression, develop new methods, technologies, and strategies for medical translation, and achieve more effective prevention, diagnosis, and treatment strategies for malignant tumors, which ultimately improve patients’ survival rates and quality of life.
